Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
New ABN Available from CMS
As of March 13, 2026, CMS has released an updated Advanced Beneficiary Notice (ABN). The revised form carries a date of March 31, 2029, and…
Join Your Community at AAA 2026
Whether you come for the evidence-based education, a plethora of practice management sessions applicable to all practice settings, the opportunity to explore the latest technology…
Academy Supports Louisiana Legislation to Update Audiology Scope of Practice
The Louisiana legislature is currently considering House Bill 925 (HB 925), introduced during the 2026 regular session. This legislation aims to update statutory definitions related…


